Efforts to prevent and halt autoimmune beta cell destruction

Michael J Haller1, Mark A Atkinson, Desmond A Schatz

  • 1Division of Endocrinology, Department of Pediatrics, University of Florida, PO Box 100296, Gainesville, FL 32610, USA. hallemj@peds.ufl.edu

Insights

Developing a cure for type 1 diabetes (T1D) remains challenging due to its complex nature and immune system

Area of Science:

  • Immunology
  • Endocrinology
  • Clinical Trials

Background:

  • Type 1 diabetes (T1D) pathophysiology is complex, with unclear triggers and immune mechanisms targeting pancreatic beta cells.
  • Despite advances in T1D natural history understanding, safe and effective prevention or reversal interventions are lacking.

Purpose of the Study:

  • To review the conceptual basis of T1D prevention and intervention trials.
  • To examine past clinical trial experiences and controversial issues in T1D interdiction.
  • To propose a roadmap for future T1D cure research.

Main Methods:

  • Review of conceptual frameworks for T1D prevention and intervention.
  • Analysis of historical clinical trial data in T1D.
  • Discussion of safety and ethical considerations in T1D research.

Main Results:

  • No consistently safe and effective intervention to prevent or reverse T1D has been developed.
  • Understanding of T1D etiology and immunologic targets remains incomplete.
  • Technological advancements in T1D management necessitate careful evaluation of high-risk interventions.

Conclusions:

  • Future T1D research requires a strategic roadmap to address knowledge gaps and guide clinical efforts.
  • Critical evaluation of trial equipoise and intervention safety is paramount.
  • Further investigation into T1D's complex pathophysiology is essential for developing a cure.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.